Winners crowned at 2019 DPC Industry Awards

By Editor
5th November 2019
Medical devices, Pharmaceutical

Pioneers and innovators were celebrated at the second annual DPC Industry Awards.

Captains of industry were rewarded for efforts to improve care for people with diabetes, with 18 trophies handed out.

The Diabetes Professional Care (DPC) Industry Awards in association with the Diabetes Times celebrated achievements, standards of excellence and commitment to quality and positive outcomes led by companies working in our community.

The ceremony took place on the evening of day one of the 2019 DPC conference, which took place on Tuesday 29 and Wednesday 30 October at Olympia London.

DPC founder Maggie Meer said: “Congratulations to all the companies and organisations, the awards are testament to their hard work, dedication, innovation and, more importantly, the life-changing difference they are making to people with diabetes.

“We launched the awards to recognise the crucial role played by industry in developing and providing products, services and research that enable people with diabetes to have better outcomes.”

Oliver Jelley, Editor of the Diabetes Times, said: “These awards are about celebrating the achievements, standards of excellence and commitment to quality and positive outcomes of the companies working in diabetes care. We were proud to be part of this positive initiative and congratulate all the winners for going above and beyond to improve diabetes care.”

Entries were judged independently by leading professionals from the diabetes community, including chair of the Association of British Clinical Diabetologists (ABCD) and Consultant in Diabetes and Endocrinology Dr Dinesh Nagi and Abigail Kitt, who is Quality Improvement Lead (Diabetes), NHS England – South East Clinical Networks.

The judges also included Professor Ketan Dhatariya, Chair of the Joint British Diabetes Societies Inpatient Group (JBDS), Dr David Lipscomb, Consultant Endocrinologist, Sussex Community Foundation NHS Trust, and Consultant Physician at Northampton General Hospital NHS Trust, Dr Anne Kilvert, University of Leicester researcher, Dr Charles Fox and Professor Alan Sinclair, Director of the Foundation for Diabetes Research in Older People (FDROP).

The Diabetes Times Excellence Award was awarded to AstraZeneca for Forxiga.  Forxiga was launched in the UK in 2012 and was the first in class SGLT2 inhibitor to market for the treatment of type 2 diabetes. Most recently, Forxiga is the first SGLT-2 to have been able to demonstrate cardiovascular benefits in a group of patients both with and without type 2 diabetes. This led to calls from cardiologists on Twitter asking diabetes teams to share “their” drug.

Medical Education Campaign of the Year
WINNER: Sanofi
HCP Education Programme of the Year
People Education Programme of the Year
WINNER: Abbott Diabetes Care
Innovation Award
Marketing Campaign of the Year
WINNER: Sanofi
Digital Health Initiative of the Year
Type 2 Diabetes Prevention Award
WINNER: Leicester Diabetes Centre
Healthy Living Initiative of the Year
Research Project of the Year
WINNER: Leicester Diabetes Centre
Product of the Year
WINNER: Roche Diabetes Care 


Most Influential Diabetes Technology Company of the Year
WINNER: Abbott Diabetes Care 
Industry Collaboration of the Year
Diabetes Charity of the Year

HIGHLY COMMENDED: Dopps International

Medical Device Company of the Year
WINNER: Insulet
Pioneer of the Year
Diabetes Times Excellence Award
WINNER: AstraZeneca
Diabetes Times Special Achievement Award
WINNER: Napp Pharmaceuticals
TREND-UK Excellence in Nursing Education Award

HIGHLY COMMENDED: Napp Pharmaceuticals

To read a summary for each winner, click here.

Comments (0)

Register an account or login to comment